Health
AstraZeneca COVID-19 shot candidate shows promise among elderly in trials – Reuters
A potential COVID-19 vaccine developed by AstraZeneca Plc and Oxford University produced a strong immune response in older adults, giving hope it may protect some…
LONDON, Nov 19 (Reuters) – A potential COVID-19 vaccine developed by AstraZeneca Plc and Oxford University produced a strong immune response in older adults, giving hope it may protect some of those most vulnerable to the disease, data from mid-stage trials showed.
The data, reported in part last month but published in full in The Lancet medical journal on Thursday, suggest that those aged over 70 – who are at higher risk of serious illness and death from COVID-19 – could build robust immunity to…
-
Noosa News21 hours agoBrisbane’s original 1979 electric trains take one last journey
-
General4 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News13 hours agoRainbow Beach surfer’s untold 7/7 story
-
General20 hours agoParis opens River Seine for public swimming for first time since 1923